mage-a4 tcr gene-modified t cells
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2012 (NCT01694472)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, passive
immunity, passive - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mage-a4 tcr gene-modified t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06170294 | Phase 1 | Jan 1, 2024 | Peking University, Shanghai Ming Ju Biotechnology Co., Ltd. |
| NCT01694472 | Phase 1 | Jul 1, 2012 | Nanjing Medical University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nanjing Medical University | Academic/Hospital | 1 | 1 | 1 | 2012 |
| Peking University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Shanghai Ming Ju Biotechnology Co., Ltd. | Government | 1 | 0 | 1 | 2024 |
3 organizations
Page 1 / 1